幕上神经外科预防性抗癫痫治疗:指南变更前后回顾性分析
该单中心回顾性前后对照研究比较了幕上开颅术后停用常规预防性抗癫痫药(AED)前后癫痫发生率。382例患者总体术后癫痫发生率为5.5%,预防组7.5% vs 无预防组2.9%(P=0.107),1个月神经功能结局无显著差异。停用常规预防未增加术后癫痫或恶化神经结局。
要点
- 停用常规预防性AED未显著增加幕上开颅术后癫痫发生率。
- 预防组术后癫痫7.5%,无预防组2.9%,差异无统计学意义(P=0.107)。
- 1个月功能自主与生活方式结局两组无显著差异。
核心结论
- 停用常规预防性抗癫痫治疗与术后癫痫增加或神经结局恶化无关。
研究设计与样本
- 单中心回顾性前后对照研究,比较停用常规抗癫痫预防前后幕上开颅术的癫痫发生率,共纳入382例患者。
主要发现
- 2019至2022年幕上开颅术后总体癫痫发生率为5.5%。
- 预防组术后癫痫发生率为7.5%,无预防组为2.9%(P=0.107)。
- 左乙拉西坦为主要AED,AED相关不良事件罕见(1.5%,P=0.283)。
- 1个月功能自主(P=0.743)与生活方式(P=0.460)两组无显著差异。
- 术后癫痫在转移瘤切除(P=0.051)和较长手术(P=0.062)患者中更常见,但未达统计学显著性。
关键数值与推荐
- 2021年欧洲指南不推荐对无癫痫发作的原发或转移性脑肿瘤患者系统性使用预防性AED。
- 本研究以术后新发癫痫为主要结局,神经状态、相关因素、AED方案及不良事件为次要结局。
临床怎么用
- 幕上开颅术后可考虑停用常规预防性AED,但需结合患者个体风险(如转移瘤切除、较长手术)评估。
局限性
- 单中心回顾性前后对照设计。
- 事件数有限,未进行多变量分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: European guidelines published in 2021 discourage the systematic use of prophylactic antiepileptic drugs (AEDs) in seizure-naïve patients with primary or metastatic brain tumors. This study aimed to assess the impact of discontinuing routine AED prophylaxis on postoperative seizure incidence and neurological outcomes. METHODS: We conducted a single-center retrospective before-after study comparing seizure incidence before and after discontinuation of routine antiepileptic prophylaxis in supratentorial craniotomies. The primary outcome was de novo postoperative seizures. Secondary outcomes included neurological status, associated factors, AED regimens, and adverse events. Univariate analysis was performed; multivariate analysis was not conducted because of the limited number of events. RESULTS: A total of 382 patients were included. The overall incidence of postoperative seizures following supratentorial craniotomy between 2019 and 2022 was 5.5%. Among patients undergoing supratentorial craniotomy, postoperative seizure incidence decreased from 7.5% in the prophylaxis group to 2.9% in the no-prophylaxis group (P = 0.107). Levetiracetam was the predominant AED. Adverse events related to AEDs were rare (1.5%, P = 0.283). Neurological outcomes at 1 month, including functional autonomy (P = 0.743) and lifestyle (P = 0.460), were not significantly different between the 2 groups. Postoperative seizures were more frequently observed in patients undergoing metastasis resection (P = 0.051) and longer surgical procedures (P = 0.062), though not reaching statistical significance. CONCLUSIONS: Stopping routine antiepileptic prophylaxis was not associated with increased postoperative seizures or worse neurological outcomes. Further studies are needed to assess the safety of newer AEDs in the postoperative setting.
引用
- Jarno JR, Subileau A, Gourier S, et al. PROCON Study: Preventive Antiepileptic Treatment in Supratentorial Neurosurgery - A Retrospective Before-After Analysis of a Change in Clinical Guidelines. World Neurosurg. 2026. PMID: 42217569. doi:10.1016/j.wneu.2026.125084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。